More on 6TdG from Dr. Shay’s lab
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Re: More on 6TdG from Dr. Shay’s lab
MAIA, after Geron, will be the #1 beneficiary of Imetelstat's NDA approval (from ODAC & FDA). The concept of a telomerase inhibitor, as an important treatment for most cancers, will have been established in 2024 as a critical breakthrough for the treatment of most cancers across the spectrum, from blood cancers to solid cancers. Then the world can consider all sorts of combinations, delivery systems, oral forms, and vaccines. John Scarlett said that 2024 will be the year to consider partners. Remember the Cancer Moonshot.